Dopamine as an immune-modulator between dendritic cells and T cells and the role of dopamine in the pathogenesis of rheumatoid arthritis

Japanese Journal of Clinical Immunology

Volumn 32, Issue 1, 2009, Pages 1-6

  Nakano, Kazuhisa ^a   Matsushita, Sho ^b   Saito, Kazuyoshi ^a   Yamaoka, Kunihiro ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Dendritic cell; Dopamine; IL 17; Rheumatoid arthritis; T cell

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOMODULATING AGENT; LYMPHOCYTE MEMBRANE RECEPTOR; NEUROTRANSMITTER;

ANTIGEN PRESENTATION; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; DENDRITIC CELL; DISEASE ASSOCIATION; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG TARGETING; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; NERVOUS SYSTEM; NEUROTRANSMITTER RELEASE; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; SCHIZOPHRENIA; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; DENDRITIC CELLS; DOPAMINE; HUMANS; IMMUNOLOGIC FACTORS; MICE; T-LYMPHOCYTES;

EID: 71749100451     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.32.1     Document Type: Review

References (16)

1. Basu SD, et al.: Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol. 102:113-112, 2000.
2. Meredith EJ, et al.: Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology. 115: 289-295, 2005.
3. Gregg D.: The paucity of arthritis among psychotic cases. Am J psychiatry. 95:853, 1939.
4. Oken R, et al.: Shizophrenia and rheumatoid arthritis: the negative association revisited. Schizophrenia Bulletin. 25: 625-638, 1999.
5. Kim YK, et al.: Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 28: 1129-1134, 2004.
6. Guermonprez P, et al.: Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol. 20: 621-627, 2002.
7. Roskoski R, et al.: Activation of tyrosine hydroxylase in PC12 cells by the cyclic GMP and cyclic AMP second messenger systems. J Neurochem. 48: 236-242, 1987.
8. Salah RS, et al.: Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices. J Neurochem. 52: 1517-1522, 1989.
9. Missale C, et al.: Dopamine Receptors: From Structure to Function. Physiol. Rev. 78: 189-225, 1998.
10. Nakano K, et al.: Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem. Biophysi. Res. Com. 373:286-291, 2008.
11. Suarez A, et al.: Generation of CD4 + CD45RA+ Effector T Cells by Stimulation in the Presence of Cyclic Adenosine 5′-Monophosphate-Elevating Agents. J Immunol 169: 1159-1167, 2002.
12. Klein-Hessling S, et al.: Protein Kinase A Regulates GATA-3-Dependent Activation of IL-5 Gene Expression in Th2 Cells. J Immunol. 170: 2956-2961, 2003.
13. + T Cell IL-4 Expression through an Adenylyl Cyclase Mechanism Independent of the Protein Kinase A Pathway. J Immunol. 175: 6361-6367, 2005.
14. Murphy CA, et al.: Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation. J. Exp. Med. 198: 1951-1957, 2003.
15. Kipnis J, et al.: Dopamine, through the Extracellular Signal-Regulated Kinase Pathway, Downregulates CD4 + CD25 + Regulatory T-Cell Activity: Implications for Neurodegeneration. J. Neurosci. 24: 6133-6143, 2004.
16. Watanabe Y, et al.: Dopamine Selectively Induces Migration and Homing of Naive CD8 + T Cells via Dopamine Receptor D3. J Immunol. 176: 848-856, 2006.